What is the current Particle Therapy Systems market size?

The Particle Therapy Systems market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Particle Therapy Systems market?

Increasing cancer incidence and technological advancements are key drivers of the market.

What are the major challenges faced by the market?

High costs and limited availability of particle therapy systems are major challenges.

Which regions are the leaders in the Particle Therapy Systems market?

North America and Europe are regional leaders, with significant market share.

Who are the top companies in the Particle Therapy Systems market?

Top companies include Varian, IBA, and Hitachi, with significant market presence.

What are the future opportunities in the Particle Therapy Systems market?

Emerging markets and advancements in technology offer future opportunities for growth.

How does technology impact the Particle Therapy Systems market?

Advances in technology, such as proton therapy, are driving market growth and innovation.

What is the current regulatory landscape of the market?

The regulatory landscape is evolving, with increasing focus on safety and efficacy.

How will the market evolve in the next 5 years?

The market will continue to grow, driven by increasing demand and technological advancements.

Global Particle Therapy Systems Market Value Is Forecast To Reach By 2034 With CAGR

Particle Therapy Systems by Application (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy), by Types (Cyclotrons, Synchrotrons, Synchrocyclotron), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Particle Therapy Systems Market Overview

The Particle Therapy Systems market refers to the industry that provides advanced cancer treatment solutions using particle therapy. As the demand for effective cancer treatments continues to rise, the Particle Therapy Systems market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $3.8 billion by 2033, driven by increasing investments in industry expansion and advancements in technology. The primary drivers of this growth include the rising prevalence of cancer, increasing adoption of particle therapy, and growing demand for advanced cancer treatment options.

Loading chart…

The growth forecast for the Particle Therapy Systems market is expected to be driven by a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033. Key forces shaping the industry include technology shifts towards more advanced and precise treatment options, regulations supporting the adoption of particle therapy, and consumer behavior driven by increasing awareness of cancer treatment options. The largest region for the Particle Therapy Systems market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing investments in healthcare infrastructure and growing demand for advanced cancer treatments. As the market continues to evolve, it is essential for industry players to stay ahead of the curve and adapt to changing market dynamics.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.43 billion
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IBA; ViewRay Technologies; Hitachi; iCAD; IsoRay; Mevion Medical Systems; Panacea Medical Technologies; P-cure; ZEISS Group; Siemens; Elekta; Accuray Incorporated
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Particle Therapy Systems market is poised for significant growth, driven by increasing demand for advanced cancer treatment options and technological advancements in the field. The Particle Therapy Systems market size is expected to expand rapidly, with a growth forecast that indicates a substantial increase in the coming years.

Growth Drivers2 items

Advances in particle therapy technology, such as improved beam delivery systems and more accurate treatment planning, are driving the adoption of Particle Therapy Systems, contributing to the growth of the Particle Therapy Systems market size

Increasing cancer incidence rates and a rising aging population are fueling the demand for effective cancer treatment options, including Particle Therapy Systems, which is expected to boost the growth forecast of the Particle Therapy Systems market

Restraints2 items

High capital expenditures required for the installation and maintenance of Particle Therapy Systems are a significant barrier to entry for many healthcare providers, limiting the growth of the Particle Therapy Systems market

Limited reimbursement options and varying regulatory frameworks across different countries and regions are hindering the widespread adoption of Particle Therapy Systems, affecting the Particle Therapy Systems market size and growth forecast

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present significant opportunities for growth, driven by increasing healthcare expenditure and a rising demand for advanced cancer treatment options, including Particle Therapy Systems, which is expected to drive the growth of the Particle Therapy Systems market

The development of hybrid Particle Therapy Systems that combine different types of radiation therapy is expected to expand the application scope of these systems, contributing to the growth forecast of the Particle Therapy Systems market size

Challenges2 items

Ensuring the safe and effective operation of Particle Therapy Systems is a significant challenge, requiring specialized training and ongoing maintenance, which can impact the growth of the Particle Therapy Systems market

Managing the high operational costs of Particle Therapy Systems, including energy consumption and maintenance expenses, is a key challenge for healthcare providers, affecting the Particle Therapy Systems market size and growth forecast

Market Segmentation

Loading chart…

The Application segment of the Particle Therapy Systems market refers to the various uses of particle therapy in medical treatments. This segment is crucial in understanding the Particle Therapy Systems segmentation, as it highlights the different areas where these systems are applied, such as cancer treatment. The application segment contributes to the overall market size by indicating the demand for particle therapy systems in various medical specialties.

The Types segment of the Particle Therapy Systems market encompasses the different types of particle therapy systems, including proton therapy systems and carbon ion therapy systems. This segmentation is vital in the market taxonomy, as it distinguishes between the various technologies used in particle therapy. The types segment contributes to the overall market size by revealing the market share of each type of system, thereby providing insights into the preferences of healthcare providers and the advancements in technology.

Particle Therapy Systems Segmentation Breakdown7 items

Application

External Beam Radiotherapy

Internal Beam Radiotherapy/Brachytherapy

Types

Cyclotrons

Synchrotrons

Synchrocyclotron

Regional Insights

Loading chart…

The Particle Therapy Systems market growth is anticipated to vary across regions, with the Asia Pacific region emerging as the largest, accounting for approximately 40% of the global market, driven by key drivers such as increasing cancer incidence, significant investments in healthcare infrastructure, and a growing ecosystem maturity. The region is also expected to be the fastest-growing, driven by factors such as rising adoption of advanced cancer treatments, favorable policies supporting healthcare development, and a rapidly expanding demographics with increasing demand for cancer care.

In North America, key drivers include high adoption rates of particle therapy systems, significant investments in research and development, and a mature ecosystem with established healthcare infrastructure. Europe is driven by factors such as increasing cancer prevalence, supportive policies for healthcare innovation, and a strong infrastructure for delivering advanced cancer treatments. Latin America and the Middle East & Africa regions are expected to experience growth driven by increasing demand for cancer care, improving infrastructure, and rising adoption of advanced therapies.

Regional Forecast5 items

Asia Pacific: 40% market share, driven by increasing cancer incidence and investments in healthcare infrastructure

North America: 30% market share, driven by high adoption rates and significant investments in research and development

Europe: 20% market share, driven by increasing cancer prevalence and supportive policies for healthcare innovation

Latin America: 5% market share, driven by increasing demand for cancer care and improving infrastructure

Middle East & Africa: 5% market share, driven by rising adoption of advanced therapies and improving infrastructure

Competitive Landscape

The Particle Therapy Systems market is moderately consolidated, driven by a mix of global players and local/regional companies. The Particle Therapy Systems competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local players concentrate on regional expansion and customization to cater to specific market needs.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves and gain a competitive edge. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

IBA: regional expansion

ViewRay Technologies: innovation pipeline

Hitachi: premium pricing

iCAD: OEM tie-ups

IsoRay: local manufacturing

Mevion Medical Systems: vertical integration

Key Particle Therapy Systems Companies12 items

IBA

ViewRay Technologies

Hitachi

iCAD

IsoRay

Mevion Medical Systems

Panacea Medical Technologies

P-cure

ZEISS Group

Siemens

Elekta

Accuray Incorporated

Market Ecosystem

The Particle Therapy Systems ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, to downstream channels and end users. This ecosystem is characterized by the creation and capture of value through the development, production, and delivery of particle therapy systems. The boundaries of this ecosystem extend from raw material and component suppliers to end users, with various intermediaries playing critical roles in the value chain.

Raw material suppliers — provide essential components

OEMs / manufacturers — design and produce systems

System integrators / EPCs — assemble and install systems

Distributors / channel partners — facilitate system sales

Service providers / after-sales — offer maintenance and support

End users / buyers — operate and utilize particle therapy systems

Regulators/standards bodies — establish and enforce industry standards

Within the Particle Therapy Systems ecosystem, control points are largely influenced by regulators and standards bodies, as well as end users who drive demand for these systems. Dependency risks arise from input constraints, such as the availability of rare earth materials, and the need for approvals from regulatory bodies. Switching costs and interoperability requirements also pose significant challenges, as particle therapy systems often require customized integration and maintenance. Furthermore, the ecosystem differs by region, with varying levels of adoption and infrastructure development in different areas, highlighting the need for a nuanced understanding of the Particle Therapy Systems ecosystem through a detailed value chain analysis.

Recent Industry Insights

The Particle Therapy Systems industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Varian Medical Systems and the University of Pennsylvania, have focused on advancing cancer treatment technologies. Additionally, there have been notable mergers and acquisitions, including the acquisition of Accuray Incorporated by a leading investment firm, aiming to expand its presence in the radiation oncology market.

Furthermore, the industry has seen the launch of innovative products and technologies, such as the introduction of proton therapy systems with advanced imaging capabilities. Regulatory changes, including the approval of new treatment protocols, have also played a crucial role in shaping the industry. A shift in consumer trends towards more personalized and effective cancer treatments has driven the demand for cutting-edge particle therapy systems, with several companies securing funding rounds to support their research and development efforts.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Particle Therapy Systems market outlook. The market exhibits moderate attractiveness due to increasing demand for advanced cancer treatment options. Competitive intensity is high, with key players investing heavily in research and development. The long-term outlook is positive, driven by growing awareness and adoption of particle therapy. The innovation landscape is rapidly evolving, with advancements in technology and treatment protocols.

The demand-supply balance is expected to stabilize as new players enter the market, addressing the current shortage of particle therapy systems. However, key risk factors include high installation costs, limited reimbursement, and regulatory hurdles. Despite these challenges, the market is poised for growth, driven by the increasing prevalence of cancer and the need for effective treatment options. Overall, the Particle Therapy Systems market presents opportunities for investors, manufacturers, and healthcare providers to capitalize on the growing demand for innovative cancer treatments.

11 items

1. Executive Summary

2. Particle Therapy Systems Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Particle Therapy Systems Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Particle Therapy Systems Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. External Beam Radiotherapy

6.1.2. Internal Beam Radiotherapy/Brachytherapy

6.2. Global Particle Therapy Systems Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Cyclotrons

6.2.2. Synchrotrons

6.2.3. Synchrocyclotron

6.3. Global Particle Therapy Systems Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Particle Therapy Systems Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Particle Therapy Systems Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Particle Therapy Systems Market Competition by Key Manufacturers

8.1. Global Particle Therapy Systems Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Particle Therapy Systems: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. IBA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ViewRay Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hitachi

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. iCAD

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. IsoRay

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Mevion Medical Systems

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Panacea Medical Technologies

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. P-cure

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ZEISS Group

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Siemens

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Elekta

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Accuray Incorporated

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Particle Therapy Systems Market

Figure 4: Global Particle Therapy Systems Market: Drivers

Figure 5: Global Particle Therapy Systems Market: Challenges

Figure 6: Global Particle Therapy Systems Market: Trends

Figure 7: Global Particle Therapy Systems Market: Opportunity

Figure 8: Global Particle Therapy Systems Market: Restraint

Figure 9: Global Particle Therapy Systems Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Particle Therapy Systems Market Value (USD Million) By Region

Figure 15: Global Particle Therapy Systems Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Particle Therapy Systems Market Value (USD Million) By Region

Figure 23: Global Particle Therapy Systems Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Particle Therapy Systems Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Particle Therapy Systems Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Particle Therapy Systems Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Particle Therapy Systems Market Value (USD Million) By Region

Table 10: Global Particle Therapy Systems Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Particle Therapy Systems Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Particle Therapy Systems Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Particle Therapy Systems Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: IBA Basic Information And Sales Area

Table 31: IBA. Products Portfolio

Table 32: ViewRay Technologies Basic Information And Sales Area

Table 33: ViewRay Technologies. Products Portfolio

Table 34: Hitachi Basic Information And Sales Area

Table 35: Hitachi. Products Portfolio

Table 36: iCAD Basic Information And Sales Area

Table 37: iCAD. Products Portfolio

Table 38: IsoRay Basic Information And Sales Area

Table 39: IsoRay. Products Portfolio

Table 40: Mevion Medical Systems Basic Information And Sales Area

Table 41: Mevion Medical Systems. Products Portfolio

Table 42: Panacea Medical Technologies Basic Information And Sales Area

Table 43: Panacea Medical Technologies. Products Portfolio

Table 44: P-cure Basic Information And Sales Area

Table 45: P-cure. Products Portfolio

Table 46: ZEISS Group Basic Information And Sales Area

Table 47: ZEISS Group. Products Portfolio

Table 48: Siemens Basic Information And Sales Area

Table 49: Siemens. Products Portfolio

Table 50: Elekta Basic Information And Sales Area

Table 51: Elekta. Products Portfolio

Table 52: Accuray Incorporated Basic Information And Sales Area

Table 53: Accuray Incorporated. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Particle Therapy Systems Market Value (USD Million) By Region

Table 59: Global Particle Therapy Systems Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Particle Therapy Systems Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.43 billion
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IBA; ViewRay Technologies; Hitachi; iCAD; IsoRay; Mevion Medical Systems; Panacea Medical Technologies; P-cure; ZEISS Group; Siemens; Elekta; Accuray Incorporated
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Particle Therapy Systems Segmentation Breakdown7 items

Application

External Beam Radiotherapy

Internal Beam Radiotherapy/Brachytherapy

Types

Cyclotrons

Synchrotrons

Synchrocyclotron

Regional Insights

Loading chart…

Regional Forecast5 items

Asia Pacific: 40% market share, driven by increasing cancer incidence and investments in healthcare infrastructure

North America: 30% market share, driven by high adoption rates and significant investments in research and development

Europe: 20% market share, driven by increasing cancer prevalence and supportive policies for healthcare innovation

Latin America: 5% market share, driven by increasing demand for cancer care and improving infrastructure

Middle East & Africa: 5% market share, driven by rising adoption of advanced therapies and improving infrastructure

Competitive Landscape

IBA: regional expansion

ViewRay Technologies: innovation pipeline

Hitachi: premium pricing

iCAD: OEM tie-ups

IsoRay: local manufacturing

Mevion Medical Systems: vertical integration

Key Particle Therapy Systems Companies12 items

IBA

ViewRay Technologies

Hitachi

iCAD

IsoRay

Mevion Medical Systems

Panacea Medical Technologies

P-cure

ZEISS Group

Siemens

Elekta

Accuray Incorporated

Market Ecosystem

Raw material suppliers — provide essential components

OEMs / manufacturers — design and produce systems

System integrators / EPCs — assemble and install systems

Distributors / channel partners — facilitate system sales

Service providers / after-sales — offer maintenance and support

End users / buyers — operate and utilize particle therapy systems

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents